Ann: Life Sciences Update, page-69

I will be taking up my allocation in the raise. Yes I could buy on market and get a few more but the amount I am putting in pales in comparison to what I currently hold. And my hope is that with enough funding this time around that perhaps we survive long enough for our technology to commercially validate the company and the next round of funding comes from a partner.

Whilst I understand all the potential opportunities that exits (thanks CB) , my gut tells me everything hinges on our Ultranode hitting 1,000 cycles at 80% retention. If we can obtain external validation that we have achieved this , then I think their would be a high probability that someone with deep pockets will acquire us , perhaps if we are lucky a few suitors may enter a bidding war to win our tech.

We are told the expectation is to hit this milestone this financial year.

I am happy to pay 2c in the raise to provide funding to give the scientists a shot , rather than on market.

And if they succeed , then we will all be the better for it , financially and otherwise.